Clinical • Trial completion date • Trial primary completion date
|
MGMT (6-O-methylguanine-DNA methyltransferase) • MDM2 (E3 ubiquitin protein ligase) • CDKN1A (Cyclin-dependent kinase inhibitor 1A)
|
ATRX mutation • MDM2 mutation
|
Avastin (bevacizumab) • temozolomide • irinotecan • Onivyde (nanoliposomal irinotecan) • SGT-53